Abstract:Objective Clustered regularly interspaced short palindromic repeats (CRISPR) has shown significant promise as an emerging nucleic acid detection technology. However, it still requires improvement in terms of sensitivity, detection automation, and anti-pollution. Furthermore, CRISPR technology lacks simple and portable professional equipment to meet the high demand of rapid point-of-care testing. Therefore, this study proposes a CRISPR/Cas12a detection reaction system for SARS-CoV-2. This detection response system and innovative tube-in-tube consumables aid in developing a portable compact device for simultaneous automatic detection of several samples and a coaxial fiber-based fluorescence detection system. Finally, we developed a single-sample user-friendly nucleic acid detection APP based on smartphone recognition and detection results for the manual detection mode. Methods The target in this study was severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which was detected using the CRISPR method and enhanced via the reverse transcription-recombinase polymerase amplification (RT-RPA) technique; the feasibility was assessed using the reverse transcription-polymerase chain reaction (RT-PCR) amplification method in the early stages. Various companies customized the required reagents and the designed sequences. In the detection process, first, with the tube-in-tube consumables developed by our team in the early stage, which comprised the reaction outer and inner tubes, the amplification reagents and detection reagents were loaded into the inner and outer tubes, respectively. The temperature was regulated to 37-42 degrees C to complete the amplification. The reagents in the inner and outer tubes were then mixed by shaking or centrifugation, and the temperature was adjusted to complete the CRISPR reaction. Finally, it was possible to observe if there was any fluorescence occurrence under the illumination of a blue light. The detection instrument was composed of an optical cassette and a base, and automatic detection was realized through a printed circuit board (PCB), a human-computer interaction display screen, etc. In addition, this study also used the fluorescence image recognition algorithm to process the detection images, compared with the international standard polymerase chain reaction (PCR) technology to explore the detection limit, and increased the target types to test the specificity strength. Results and Discussions The lower part of the detection instrument designed by our team integrates the printed circuit board and the human-computer interaction display screen. In the automatic detection mode, the fluorescence recognition circuit was designed with the help of a 470 nm light-emitting diode (LED), an optical filter, a complementary metal oxide semiconductor (CMOS) camera, a collimating lens, and a coaxial fiber. At the same time, the specificity of the theoretical experiment was verified through comparative experiments on several different targets. In addition, to verify the accuracy of this method for detecting actual samples, we compared each actual sample through PCR detection and the method based on the combination of RT-RPA and CRISPR proposed in this study. The detection results showed that the two were perfectly consistent. Conclusions The current study proposed a CRISPR/Cas12a-based anti-pollution portable nucleic acid detection technique. Furthermore, a simple model was proposed based on the naked eye or smartphone to recognize results; additionally, a downsized portable device based on fluorescence detection that can simultaneously detect numerous samples was constructed. The portable device can detect numerous samples simultaneously, and it has a constant heating mechanism and fluorescence stimulation detection optical channel to enhance the detection system's accuracy and stability. The nucleic acid of SARS-CoV-2 was verified using the proposed method and detection system. The minimum detection limit was <10 copy/mu L. The test findings of our method had a good consistency with that of real-time fluorescence quantitative PCR method, but our method took less than half the time consuming of the PCR method, and the whole detection process could be finished in 32 min. The method and technology developed in this study propose a novel approach for nucleic acid detection at health-care center and home.

DECODE: Contamination-Free Digital CRISPR Platform for Point-of-Care Detection of Viral DNA/RNA

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Ultrafast Visual Nucleic Acid Detection with CRISPR/Cas12a and Rapid PCR in Single Capillary

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Integrated Dual Nucleic Acid Analysis by Slip Valve-Assisted Fluidic Chip Combined with CRISPR/Cas12a Detection

Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12a

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processing

Portable all-in-one microfluidic system for CRISPR-Cas13a-based fully integrated multiplexed nucleic acid detection

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

DropCRISPR: A LAMP-Cas12a Based Digital Method for Ultrasensitive Detection of Nucleic Acid.

A Versatile CRISPR Cas12a-based Point-of-care Biosensor Enabling Convenient Glucometer Readout for Ultrasensitive Detection of Pathogen Nucleic Acids.

Rapid and Amplification-free Nucleic Acid Detection with DNA Substrate-Mediated Autocatalysis of CRISPR/Cas12a

PddCas: A Polydisperse Droplet Digital CRISPR/Cas-Based Assay for the Rapid and Ultrasensitive Amplification-Free Detection of Viral DNA/RNA

A universal all-in-one RPA-Cas12a strategy with de novo autodesigner and its application in on-site ultrasensitive detection of DNA and RNA viruses

A universal nucleic acid detection platform combing CRISPR/Cas12a and strand displacement amplification with multiple signal readout

A One-Pot CRISPR/Cas13a-based Contamination-Free Biosensor for Low-Cost and Rapid Nucleic Acid Diagnostics

An automated nucleic acid detection platform using digital microfluidics with an optimized Cas12a system

Integrated slip valve-assisted fluidic chip coupling with CRISPR/Cas12a system for nucleic acid analysis

Convenient Nucleic Acid Detection Method and Point-of-Care Detection Device Based on CRISPR/Cas12a Molecular Diagnosis

Automated Microfluidic Nucleic Acid Detection Platform-Integrated RPA-T7-Cas13a for Pathogen Diagnosis